Immune Cell Inhibition by SLAMF7 Is Mediated by a Mechanism Requiring Src Kinases, CD45, and SHIP-1 That Is Defective in Multiple Myeloma Cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune Cell Inhibition by SLAMF7 Is Mediated by a Mechanism Requiring Src Kinases, CD45, and SHIP-1 That Is Defective in Multiple Myeloma Cells
Authors
Keywords
-
Journal
MOLECULAR AND CELLULAR BIOLOGY
Volume 35, Issue 1, Pages 41-51
Publisher
American Society for Microbiology
Online
2014-10-14
DOI
10.1128/mcb.01107-14
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EAT-2, a SAP-like adaptor, controls NK cell activation through phospholipase Cγ, Ca++, and Erk, leading to granule polarization
- (2014) Luis-Alberto Pérez-Quintero et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC
- (2013) Shauna M. Collins et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CS1, a SLAM family receptor involved in immune regulation, is a therapeutic target in multiple myeloma
- (2013) André Veillette et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Elotuzumab: a novel anti-CS1 monoclonal antibody for the treatment of multiple myeloma
- (2013) Sagar Lonial et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Mouse natural killer cell development and maturation are differentially regulated by SHIP-1
- (2012) C. Banh et al. BLOOD
- The Adaptor SAP Controls NK Cell Activation by Regulating the Enzymes Vav-1 and SHIP-1 and by Enhancing Conjugates with Target Cells
- (2012) Zhongjun Dong et al. IMMUNITY
- Positive and Negative Signaling through SLAM Receptors Regulate Synapse Organization and Thresholds of Cytolysis
- (2012) Fang Zhao et al. IMMUNITY
- The Receptor Ly108 Functions as a SAP Adaptor-Dependent On-Off Switch for T Cell Help to B Cells and NKT Cell Development
- (2012) Robin Kageyama et al. IMMUNITY
- Phase I Trial of Anti-CS1 Monoclonal Antibody Elotuzumab in Combination With Bortezomib in the Treatment of Relapsed/Refractory Multiple Myeloma
- (2012) Andrzej J. Jakubowiak et al. JOURNAL OF CLINICAL ONCOLOGY
- Elotuzumab in Combination With Lenalidomide and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma
- (2012) Sagar Lonial et al. JOURNAL OF CLINICAL ONCOLOGY
- CD19−CD45low/−CD38high/CD138+ plasma cells enrich for human tumorigenic myeloma cells
- (2012) D Kim et al. LEUKEMIA
- Protein tyrosine phosphatases in lymphocyte activation and autoimmunity
- (2012) Inmoo Rhee et al. NATURE IMMUNOLOGY
- SLAM Family Receptors and SAP Adaptors in Immunity
- (2011) Jennifer L. Cannons et al. Annual Review of Immunology
- A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced multiple myeloma
- (2011) J. A. Zonder et al. BLOOD
- Altered expression of signalling lymphocyte activation molecule (SLAM) family receptors CS1 (CD319) and 2B4 (CD244) in patients with systemic lupus erythematosus
- (2010) J. R. Kim et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- SLAM-Family Receptors: Immune Regulators with or without SAP-Family Adaptors
- (2010) A. Veillette Cold Spring Harbor Perspectives in Biology
- NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo
- (2009) Tadepally Lakshmikanth et al. JOURNAL OF CLINICAL INVESTIGATION
- Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma
- (2009) F. van Rhee et al. MOLECULAR CANCER THERAPEUTICS
- Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells
- (2009) Zhongjun Dong et al. NATURE IMMUNOLOGY
- Influence of CRACC, a SLAM family receptor coupled to the adaptor EAT-2, on natural killer cell function
- (2009) Mario-Ernesto Cruz-Munoz et al. NATURE IMMUNOLOGY
- CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma
- (2008) E. D. Hsi et al. CLINICAL CANCER RESEARCH
- Structurally Distinct Phosphatases CD45 and CD148 Both Regulate B Cell and Macrophage Immunoreceptor Signaling
- (2008) Jing W. Zhu et al. IMMUNITY
- Accelerated tumor growth in mice deficient in DNAM-1 receptor
- (2008) Akiko Iguchi-Manaka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Phospholipase C-γ2 and Vav cooperate within signaling microclusters to propagate B cell spreading in response to membrane-bound antigen
- (2008) Michele Weber et al. JOURNAL OF EXPERIMENTAL MEDICINE
- DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors
- (2008) Susan Gilfillan et al. JOURNAL OF EXPERIMENTAL MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now